Flare up, Flare Up, Symptom, Postoperative Pain
Conditions
Keywords
postoperative pain, flare up, nano-technology, irrigation, chitosan, aloe-vera
Brief summary
This study aimed to evaluate and compare impact of integrating passive ultrasonic activation and laser activation with nano-chitosan and aloe vera in terms of postoperative pain and flare-up incidence in a randomized clinical trial.
Interventions
using Chitosan Nanoparticles irrigant as a final irrigation solution.
using Aloe Vera Nanoparticles irrigant as a final irrigation solution.
activation of nanoparticles irrigants using diode laser
activation of nanoparticles irrigants using ultrasonic activator
Sponsors
Study design
Eligibility
Inclusion criteria
* Age 18-60 (adults only) * multiple-rooted with multiple root canal. * Permanent teeth with mature apex and complete root formation. * Without root caries. * Tooth must be restorable. * Without anatomical abnormalities such as fusion. * Healthy patient category I according to ASA. * Vital tooth, with acute irreversible pulpitis and without peri-apical periodontitis. * No periapical radiolucency. * Consent Patients for who consent to participate and attend follow-up appointments.
Exclusion criteria
* single root canals or double root. * Root canal calcifications. * Root resorption or fracture. * Previously root canal treated teeth. * immunocompromised patients. * Pregnant females * Patients with systemic diseases as diabetic or hypertension patients. * Patients with facial swelling. * patients who use analgesics or antibiotics within 48-72 hours. * Allergy to any materials used (e.g., irrigants or anesthetics). * psychiatric illness * Teeth that are not indicated for endodontic treatment: bad oral hygiene, mobile teeth, or recessed teeth. * Previously endodontically treated teeth. * Teeth with sinus tract.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative pain intensity Postoperative pain is to be assessed using visual analog scale (VAS), A scale from (0 to 10) where 0 means no pain and 10 means a severe pain that has never faced before. | [Time Frame: 6, 12, 24, 48, 72 hours and 7 days after the first visit to collect the postoperative pain data.] | Patients will be contacted by phone at 6, 12, 24, 48, 72 hours and 7 days after the first visit to collect the postoperative pain data. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Flare-Up Incidence Flare-up is assessed through asking the patient to notify the investigator if any sudden severe pain or swelling takes place. | [Time Frame: Within 7 days post-treatment) | This could require an unscheduled emergency visit or prescription of additional medication. |